Absci to Participate in Upcoming Investor Conferences
Absci (Nasdaq: ABSI), a data-first generative AI drug creation company, has announced its participation in three upcoming investor conferences in September 2024:
- Morgan Stanley 22nd Annual Global Healthcare Conference: Fireside chat on September 5th at 5:35 p.m. ET
- Citi 2024 Global TMT Conference: Fireside chat on September 6th at 8:20 a.m. ET
- H.C. Wainwright 26th Annual Global Investment Conference: Fireside chat on September 10th at 12:00 p.m. ET
Interested parties can access live and archived webcasts of these events on Absci's investor relations website at investors.absci.com.
Absci (Nasdaq: ABSI), una compagnia di creazione di farmaci generativa AI basata sui dati, ha annunciato la sua partecipazione a tre conferenze per investitori che si terranno a settembre 2024:
- Morgan Stanley 22ª Conferenza Globale sulla Salute: Chat informale il 5 settembre alle 17:35 ET
- Citi 2024 Conferenza Globale TMT: Chat informale il 6 settembre alle 8:20 ET
- H.C. Wainwright 26ª Conferenza Globale sugli Investimenti: Chat informale il 10 settembre alle 12:00 ET
Le parti interessate possono accedere alle dirette e alle registrazioni di questi eventi sul sito web delle relazioni con gli investitori di Absci all'indirizzo investors.absci.com.
Absci (Nasdaq: ABSI), una empresa de creación de medicamentos basada en IA generativa y centrada en datos, ha anunciado su participación en tres conferencias para inversores que se celebrarán en septiembre de 2024:
- Conferencia Global Anual de Salud de Morgan Stanley: Charla informal el 5 de septiembre a las 5:35 p.m. ET
- Conferencia Global TMT 2024 de Citi: Charla informal el 6 de septiembre a las 8:20 a.m. ET
- Conferencia Global de Inversiones Anual de H.C. Wainwright: Charla informal el 10 de septiembre a las 12:00 p.m. ET
Las partes interesadas pueden acceder a las transmisiones en vivo y grabadas de estos eventos en el sitio web de relaciones con inversores de Absci en investors.absci.com.
Absci (Nasdaq: ABSI)는 데이터 기반의 생성적 AI 약물 제작 회사로서, 2024년 9월에 열리는 세 가지 투자자 컨퍼런스에 참여할 것이라고 발표했습니다:
- 모건 스탠리 제22회 글로벌 헬스케어 컨퍼런스: 9월 5일 오후 5:35 ET에 진행되는 파이어사이드 채팅
- 씨티 2024 글로벌 TMT 컨퍼런스: 9월 6일 오전 8:20 ET에 진행되는 파이어사이드 채팅
- H.C. 웨인라이트 제26회 글로벌 투자 컨퍼런스: 9월 10일 오후 12:00 ET에 진행되는 파이어사이드 채팅
관심 있는 방문객은 Absci의 투자자 관계 웹사이트인 investors.absci.com에서 이들 이벤트의 실시간 및 아카이브 방송을 확인할 수 있습니다.
Absci (Nasdaq: ABSI), une entreprise de création de médicaments utilisant l'IA générative et fondée sur les données, a annoncé sa participation à trois conférences pour investisseurs prévues en septembre 2024 :
- 22e conférence mondiale sur la santé de Morgan Stanley : discussion informelle le 5 septembre à 17h35 ET
- Conférence mondiale TMT 2024 de Citi : discussion informelle le 6 septembre à 8h20 ET
- 26e conférence mondiale sur les investissements de H.C. Wainwright : discussion informelle le 10 septembre à 12h00 ET
Les parties intéressées peuvent accéder aux diffusions en direct et aux archives de ces événements sur le site Web des relations avec les investisseurs d'Absci à l'adresse investors.absci.com.
Absci (Nasdaq: ABSI), ein auf Daten basierendes Unternehmen für die Generierung von KI-Arzneimitteln, hat seine Teilnahme an drei bevorstehenden Investorenkonferenzen im September 2024 bekannt gegeben:
- Morgan Stanley 22. Jahreskonferenz für globale Gesundheitsversorgung: Fireside-Chat am 5. September um 17:35 Uhr ET
- Citi 2024 globale TMT-Konferenz: Fireside-Chat am 6. September um 8:20 Uhr ET
- H.C. Wainwright 26. Jahreskonferenz für globale Investitionen: Fireside-Chat am 10. September um 12:00 Uhr ET
Interessierte Parteien können die Live-Übertragungen und Archive dieser Veranstaltungen auf der Investor-Relations-Website von Absci unter investors.absci.com einsehen.
- None.
- None.
VANCOUVER, Wash. and NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the following upcoming investor conferences.
- Morgan Stanley 22nd Annual Global Healthcare Conference
Fireside chat on Thursday, September 5th at 5:35 p.m. Eastern Time
- Citi 2024 Global TMT Conference
Fireside chat on Friday, September 6th at 8:20 a.m. Eastern Time
- H.C. Wainwright 26th Annual Global Investment Conference
Fireside chat on Tuesday, September 10th at 12:00 p.m. Eastern Time
Interested parties may access live and archived webcasts of these events on the company’s investor relations website at: investors.absci.com.
About Absci
Absci is a data-first generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster. Our Integrated Drug Creation™ platform unlocks the potential to accelerate time to clinic and increase the probability of success by simultaneously optimizing multiple drug characteristics important to both development and therapeutic benefit. With the data to train, the AI to create, and the wet lab to validate, we can screen billions of cells per week, allowing us to go from AI-designed candidates to wet lab-validated candidates in as little as six weeks. Absci’s headquarters is in Vancouver, WA, with our AI Research Lab in New York City and an Innovation Center in Zug, Switzerland. Visit www.absci.com and follow us on LinkedIn (@absci), X (Twitter) (@Abscibio), and YouTube.
Investor Contact
Alex Khan
VP, Finance & Investor Relations
investors@absci.com
Media Contact
press@absci.com
FAQ
What investor conferences will Absci (ABSI) participate in during September 2024?
When is Absci's (ABSI) fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference?
How can investors access Absci's (ABSI) conference webcasts?
What type of company is Absci (ABSI) described as in the press release?
